Alpha-synuclein is increased in erythrocytes in parkinson’s disease cases

Abstract Idiopathic Parkinson’s disease (iPD) is the second most common neurodegenerative disease after Alzheimer’s disease (AD). Mutations in the SCNA gene, which encodes the protein alpha synuclein (α-syn), are associated with familial forms of Parkinson’s disease (PD). Additionally, Lewy bodies (...

Full description

Bibliographic Details
Published in:Scientific Reports
Main Authors: Ryan N. Coyle, Anne M. Roberts, Malcolm Horne, Christopher Fowler, Colin L. Masters, Blaine R. Roberts
Format: Article
Language:English
Published: Nature Portfolio 2025-08-01
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-11979-8
_version_ 1849327365935595520
author Ryan N. Coyle
Anne M. Roberts
Malcolm Horne
Christopher Fowler
Colin L. Masters
Blaine R. Roberts
author_facet Ryan N. Coyle
Anne M. Roberts
Malcolm Horne
Christopher Fowler
Colin L. Masters
Blaine R. Roberts
author_sort Ryan N. Coyle
collection DOAJ
container_title Scientific Reports
description Abstract Idiopathic Parkinson’s disease (iPD) is the second most common neurodegenerative disease after Alzheimer’s disease (AD). Mutations in the SCNA gene, which encodes the protein alpha synuclein (α-syn), are associated with familial forms of Parkinson’s disease (PD). Additionally, Lewy bodies (LBs) rich in α-synuclein are a hallmark of idiopathic Parkinson’s disease (iPD) pathology. Unlike AD, there are no effective blood-based diagnostic assays for iPD. Recent studies show that measures of misfolded α-syn in cerebrospinal fluid (CSF) and skin biopsies reflect the diagnosis of iPD. The presence of misfolded α-syn suggests that the altered cellular processes in the brain that lead to aggregated α-syn may also occur in the periphery. However, CSF and skin biopsies are intrusive, highlighting the need for a blood-based diagnostic assay. Erythrocytes are the richest source of α-syn in the body, and we hypothesized that peripheral α-syn changes could be detected in erythrocytes in iPD. To test this hypothesis, we used a targeted liquid chromatography-mass spectrometry (LC-MS) assay, that included 15N-enriched recombinant α-syn as an internal standard. We compared the levels of α-syn in erythrocytes from iPD patients, AD patients, and healthy controls (CN). α-syn concentrations were significantly elevated in iPD (48.1 (29.7) µg mL-1 of erythrocytes, median (IQR)) compared to CN (36.1 (28.4) µg mL-1) and no difference was observed in AD (33.5 (18.1) µg mL-1). Although α-syn levels were significantly elevated in iPD, the receiver operating characteristic (ROC) analysis yielded an area under the curve (AUC) of 0.62, indicating that erythrocytic α-syn levels alone are not sufficient for diagnostic purposes.
format Article
id doaj-art-da9952a749de491a8d6cffe78329c27e
institution Directory of Open Access Journals
issn 2045-2322
language English
publishDate 2025-08-01
publisher Nature Portfolio
record_format Article
spelling doaj-art-da9952a749de491a8d6cffe78329c27e2025-08-31T11:25:24ZengNature PortfolioScientific Reports2045-23222025-08-011511710.1038/s41598-025-11979-8Alpha-synuclein is increased in erythrocytes in parkinson’s disease casesRyan N. Coyle0Anne M. Roberts1Malcolm Horne2Christopher Fowler3Colin L. Masters4Blaine R. Roberts5Department of Biochemistry, Emory UniversityDepartment of Biochemistry, Emory UniversityBionics InstituteFlorey Institute, The University of MelbourneFlorey Institute, The University of MelbourneDepartment of Biochemistry, Emory UniversityAbstract Idiopathic Parkinson’s disease (iPD) is the second most common neurodegenerative disease after Alzheimer’s disease (AD). Mutations in the SCNA gene, which encodes the protein alpha synuclein (α-syn), are associated with familial forms of Parkinson’s disease (PD). Additionally, Lewy bodies (LBs) rich in α-synuclein are a hallmark of idiopathic Parkinson’s disease (iPD) pathology. Unlike AD, there are no effective blood-based diagnostic assays for iPD. Recent studies show that measures of misfolded α-syn in cerebrospinal fluid (CSF) and skin biopsies reflect the diagnosis of iPD. The presence of misfolded α-syn suggests that the altered cellular processes in the brain that lead to aggregated α-syn may also occur in the periphery. However, CSF and skin biopsies are intrusive, highlighting the need for a blood-based diagnostic assay. Erythrocytes are the richest source of α-syn in the body, and we hypothesized that peripheral α-syn changes could be detected in erythrocytes in iPD. To test this hypothesis, we used a targeted liquid chromatography-mass spectrometry (LC-MS) assay, that included 15N-enriched recombinant α-syn as an internal standard. We compared the levels of α-syn in erythrocytes from iPD patients, AD patients, and healthy controls (CN). α-syn concentrations were significantly elevated in iPD (48.1 (29.7) µg mL-1 of erythrocytes, median (IQR)) compared to CN (36.1 (28.4) µg mL-1) and no difference was observed in AD (33.5 (18.1) µg mL-1). Although α-syn levels were significantly elevated in iPD, the receiver operating characteristic (ROC) analysis yielded an area under the curve (AUC) of 0.62, indicating that erythrocytic α-syn levels alone are not sufficient for diagnostic purposes.https://doi.org/10.1038/s41598-025-11979-8Red blood cellsAlpha synucleinParkinson’s diseaseErythrocytesQQQProteomics
spellingShingle Ryan N. Coyle
Anne M. Roberts
Malcolm Horne
Christopher Fowler
Colin L. Masters
Blaine R. Roberts
Alpha-synuclein is increased in erythrocytes in parkinson’s disease cases
Red blood cells
Alpha synuclein
Parkinson’s disease
Erythrocytes
QQQ
Proteomics
title Alpha-synuclein is increased in erythrocytes in parkinson’s disease cases
title_full Alpha-synuclein is increased in erythrocytes in parkinson’s disease cases
title_fullStr Alpha-synuclein is increased in erythrocytes in parkinson’s disease cases
title_full_unstemmed Alpha-synuclein is increased in erythrocytes in parkinson’s disease cases
title_short Alpha-synuclein is increased in erythrocytes in parkinson’s disease cases
title_sort alpha synuclein is increased in erythrocytes in parkinson s disease cases
topic Red blood cells
Alpha synuclein
Parkinson’s disease
Erythrocytes
QQQ
Proteomics
url https://doi.org/10.1038/s41598-025-11979-8
work_keys_str_mv AT ryanncoyle alphasynucleinisincreasedinerythrocytesinparkinsonsdiseasecases
AT annemroberts alphasynucleinisincreasedinerythrocytesinparkinsonsdiseasecases
AT malcolmhorne alphasynucleinisincreasedinerythrocytesinparkinsonsdiseasecases
AT christopherfowler alphasynucleinisincreasedinerythrocytesinparkinsonsdiseasecases
AT colinlmasters alphasynucleinisincreasedinerythrocytesinparkinsonsdiseasecases
AT blainerroberts alphasynucleinisincreasedinerythrocytesinparkinsonsdiseasecases